
A study of 2,487 prostate cancer patients presented at the ESC Congress 2026 shows that managing cardiovascular risk factors improves patient outcomes.
Patients with total cholesterol above 4 mmol/L or elevated blood pressure showed more favorable responses to structured cardiovascular interventions.
The RADICAL PC-2 trial evaluated the impact of referrals to cardiologists for statin therapy and lifestyle modifications on cardiovascular death, heart failure, and stroke rates.